NEW: No-Cost Streetwise Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More
Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Avadel Pharmaceuticals is a branded specialty pharmaceutical company. The company's primary focus is on the development and potential FDA approval for FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. In addition, Avadel develops and markets a portfolio of sterile injectable drugs used in the hospital setting.